Background Imaging techniques are used to identify local recurrence of prostate cancer
(PCa) for salvage therapy and to exclude metastases that should be addressed with …

Radiation therapy to the prostate involves increasingly sophisticated delivery techniques
and changing fractionation schedules. With a low estimated α/β ratio, a larger dose per …

Purpose One of the major challenges for all imaging modalities is accurate detection of
prostate cancer (PCa) recurrence. Beyond the established 68 Ga-PSMA, a novel promising …

68Ga-prostate-specific membrane antigen (PSMA) PET/CT is a promising diagnostic tool for
patients with prostate cancer. Our study evaluates SUVs in benign prostate tissue and …

Prostate cancer may recur several years after definitive treatment, such as prostatectomy or
radiation therapy. A rise in serum prostate-specific antigen (PSA) level is the first sign of …

Prostate cancer (PCa) is the most common solid organ malignancy and second most
common cause of cancer-related deaths among men in the United States. Last year …

Purpose Our purpose was to report 5-year efficacy and toxicity of intraprostatic lesion
boosting using standard and hypofractionated radiation therapy. Methods and Materials …

Introduction Long-term outcomes from large cohorts are not yet available upon which to
base recommended follow-up protocols after prostate focal therapy. This is an updated …

Brachytherapy has become an essential pillar in all-stages of localized prostate cancer,
where dose escalation has been demonstrated to improve outcome. HDR brachytherapy …

Background and purpose To demonstrate the feasibility, safety and effectiveness of dose
escalation to intraprostatic lesions with MRI-transrectal ultrasound fusion High-Dose-Rate …